Literature DB >> 2828271

Effects of the anaphylatoxins on circulation.

F Marceau1, C Lundberg, T E Hugli.   

Abstract

Mesh：

Substances：

Year:  1987        PMID： 2828271     DOI： 10.1016/0162-3109(87)90031-2

Source DB:  PubMed          Journal:  Immunopharmacology        ISSN： 0162-3109


× No keyword cloud information.
  11 in total

Review 1.  Evolution of complement as an effector system in innate and adaptive immunity.

Authors:  J Oriol Sunyer; Hani Boshra; Gema Lorenzo; David Parra; Bruce Freedman; Nina Bosch
Journal:  Immunol Res       Date:  2003       Impact factor: 2.829

2.  Species dependence for binding of small molecule agonist and antagonists to the C5a receptor on polymorphonuclear leukocytes.

Authors:  T M Woodruff; A J Strachan; S D Sanderson; P N Monk; A K Wong; D P Fairlie; S M Taylor
Journal:  Inflammation       Date:  2001-06       Impact factor: 4.092

3.  Effects of a new C5a receptor antagonist on C5a- and endotoxin-induced neutropenia in the rat.

Authors:  A Short; A K Wong; A M Finch; G Haaima; I A Shiels; D P Fairlie; S M Taylor
Journal:  Br J Pharmacol       Date:  1999-02       Impact factor: 8.739

4.  De novo peptide design with C3a receptor agonist and antagonist activities: theoretical predictions and experimental validation.

Authors:  Meghan L Bellows-Peterson; Ho Ki Fung; Christodoulos A Floudas; Chris A Kieslich; Li Zhang; Dimitrios Morikis; Kathryn J Wareham; Peter N Monk; Owen A Hawksworth; Trent M Woodruff
Journal:  J Med Chem       Date:  2012-04-20       Impact factor: 7.446

5.  Pharmacological characterization of antagonists of the C5a receptor.

Authors:  N J Paczkowski; A M Finch; J B Whitmore; A J Short; A K Wong; P N Monk; S A Cain; D P Fairlie; S M Taylor
Journal:  Br J Pharmacol       Date:  1999-12       Impact factor: 8.739

Review 6.  To PEGylate or not to PEGylate: Immunological properties of nanomedicine's most popular component, polyethylene glycol and its alternatives.

Authors:  Da Shi; Damian Beasock; Adam Fessler; Janos Szebeni; Julia Y Ljubimova; Kirill A Afonin; Marina A Dobrovolskaia
Journal:  Adv Drug Deliv Rev       Date:  2021-12-10       Impact factor: 15.470

7.  Acute physiological changes caused by complement activators and amphotericin B-containing liposomes in mice.

Authors:  Erik Őrfi; Tamás Mészáros; Mark Hennies; Tamás Fülöp; László Dézsi; Alexander Nardocci; László Rosivall; Péter Hamar; Barry W Neun; Marina A Dobrovolskaia; János Szebeni; Gábor Szénási
Journal:  Int J Nanomedicine       Date:  2019-02-26

Review 8.  Hypersensitivity reactions to radiocontrast media: the role of complement activation.

Authors:  Janos Szebeni
Journal:  Curr Allergy Asthma Rep       Date:  2004-01       Impact factor: 4.919

Review 9.  Immunological and Toxicological Considerations for the Design of Liposomes.

Authors:  Collin T Inglut; Aaron J Sorrin; Thilinie Kuruppu; Shruti Vig; Julia Cicalo; Haroon Ahmad; Huang-Chiao Huang
Journal:  Nanomaterials (Basel)       Date:  2020-01-22       Impact factor: 5.076

10.  Proteomic and Biological Analysis of an In Vitro Human Endothelial System in Response to Drug Anaphylaxis.

Authors:  Alma Yuste-Montalvo; Sergio Fernandez-Bravo; Tamara Oliva; Carlos Pastor-Vargas; Diana Betancor; María José Goikoetxea; José Julio Laguna; Juan Antonio López; Gloria Alvarez-Llamas; Javier Cuesta-Herranz; Marta Martin-Lorenzo; Vanesa Esteban
Journal:  Front Immunol       Date:  2021-06-25       Impact factor: 7.561
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.